14,053 Shares in PTC Inc. $PTC Acquired by Bank of Nova Scotia

Bank of Nova Scotia purchased a new stake in PTC Inc. (NASDAQ:PTC) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 14,053 shares of the technology company’s stock, valued at approximately $1,597,000.

Several other hedge funds have also recently bought and sold shares of the stock. Kirtland Hills Capital Management LLC acquired a new stake in shares of PTC in the 2nd quarter valued at $278,000. Daiichi Life Insurance Co. Ltd. acquired a new stake in shares of PTC during the 2nd quarter worth about $5,674,000. Commerce Bank acquired a new stake in shares of PTC during the 2nd quarter worth about $8,312,000. Northwestern Mutual Wealth Management Co. bought a new position in PTC during the 2nd quarter valued at about $255,000. Finally, Quantbot Technologies LP bought a new position in PTC during the 2nd quarter valued at about $115,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have weighed in on PTC. Citigroup upped their price objective on shares of PTC from $127.00 to $141.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Weiss Ratings reiterated a “hold (c-)” rating on shares of PTC in a research note on Monday, August 3rd. Berenberg Bank set a $170.00 target price on PTC in a report on Wednesday, May 27th. BNP Paribas Exane started coverage on PTC in a research report on Thursday, June 18th. They set a “neutral” rating and a $130.00 price target on the stock. Finally, Stifel Nicolaus dropped their price target on PTC from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $170.14.

PTC Price Performance

Shares of PTC stock opened at $151.61 on Thursday. The firm has a market cap of $16.45 billion, a price-to-earnings ratio of 14.66, a PEG ratio of 2.16 and a beta of 0.98. PTC Inc. has a 12 month low of $108.50 and a 12 month high of $217.64. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.40. The stock has a 50-day moving average price of $131.35 and a 200 day moving average price of $140.14.

PTC (NASDAQ:PTC) last released its earnings results on Wednesday, July 29th. The technology company reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.01. The company had revenue of $600.05 million for the quarter, compared to the consensus estimate of $611.62 million. PTC had a net margin of 41.67% and a return on equity of 25.31%. The company’s revenue was down 6.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.64 EPS. PTC has set its FY 2026 guidance at 7.870-8.420 EPS and its Q4 2026 guidance at 1.630-2.210 EPS. Research analysts expect that PTC Inc. will post 6.51 EPS for the current year.

PTC Profile

PTC Inc (NASDAQ: PTC) is a global technology company that develops software and services to help manufacturers design, operate, and service physical products. Founded in 1985 as Parametric Technology Corporation, PTC pioneered parametric, feature-based CAD with its Pro/ENGINEER product (now marketed as Creo) and has since expanded its portfolio to address product lifecycle management, Internet of Things (IoT), augmented reality (AR) and industrial connectivity.

Key product lines include Creo for 3D CAD; Windchill for product lifecycle management (PLM); ThingWorx, an IoT platform for connecting devices and building industrial applications; Vuforia, an AR platform for creating immersive service and training experiences; and Kepware, a suite for industrial connectivity and protocol translation.